A clinical study of ACE1655
Latest Information Update: 28 Oct 2020
At a glance
- Drugs ACE 1655 (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- 28 Oct 2020 New trial record
- 22 Oct 2020 According to an Acepodia media release, the company plans to initiate this study.